Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema (TA953)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 March 2024
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes (TA943)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 19 December 2023
Tirzepatide for treating type 2 diabetes (TA924)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 October 2023
Endoscopic duodenal mucosal resurfacing for type 2 diabetesStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 11 May 2024
Type 2 diabetes in adults: management (medicines update)Status:In developmentProgramme:NICE guidelineExpected publication date: 4 December 2024
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition [ID6259]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Cardiometabolic disease prevention and treatment guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC